First in Man Study With SLV341

Solvay

Status and phase: Terminated; Phase 1

Conditions: Diabetes

Treatments: Drug: placebo; Drug: SLV341

Study type: Interventional

Funder types: Industry

Identifiers

NCT00887445

2007-007196-17

00887445

S341.1.001

Details and patient eligibility

About

First in man study with single and multiple rising doses with SLV341

Enrollment: 87 patients

Sex: Male

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria healthy Exclusion Criteria not healthy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

87 participants in 2 patient groups, including a placebo group

A

Experimental group

Treatment:

Drug: SLV341

B

Placebo Comparator group

Treatment:

Drug: placebo